Drugs / VTP-38543
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02655679 | Dec 2015 → Sep 2016 | atopic eczema | Vitae Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VTP-38543 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02655679 ↗ |
| Route | Topical | “VTP-38543 0.05% administered topically every 12 hours for 28 days.” NCT02655679 ↗ |